Integral Derivatives’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.07M Sell
5,000
-36,200
-88% -$8.27M 0.03% 222
2017
Q4
$9.08M Buy
41,200
+7,800
+23% +$1.65M 0.18% 52
2017
Q3
$6.54M Buy
33,400
+13,000
+64% +$2.51M 0.12% 106
2017
Q2
$3.78M Buy
20,400
+8,100
+66% +$1.42M 0.08% 153
2017
Q1
$2.02M Sell
12,300
-12,200
-50% -$2M 0.04% 304
2016
Q4
$3.92M Buy
24,500
+10,400
+74% +$1.55M 0.07% 177
2016
Q3
$1.97M Buy
14,100
+4,700
+50% +$658K 0.04% 270
2016
Q2
$1.33M Sell
9,400
-1,900
-17% -$253K 0.03% 332
2016
Q1
$1.46M Sell
11,300
-25,200
-69% -$2.98M 0.05% 282
2015
Q4
$4.29M Buy
36,500
+12,600
+53% +$1.47M 0.11% 146
2015
Q3
$2.77M Sell
23,900
-36,400
-60% -$4.36M 0.08% 228
2015
Q2
$7.36M Buy
60,300
+42,800
+245% +$5.06M 0.2% 90
2015
Q1
$2.07M Buy
+17,500
New +$1.94M 0.04% 288
2014
Q2
Sell
-5,500
Closed -$451K 1521
2014
Q1
$451K Buy
+5,500
New +$414K 0.01% 917

Other funds holding UNH

Integral Derivatives's UNH Position: Q1 2018 in Review

Integral Derivatives increased its UnitedHealth (UNH) stake by 8.8% in Q1 2018, buying an estimated $78.8K and bringing the position to 4,270 shares worth $914K. The position accounts for 0.02% of the portfolio, ranked #259.

Integral Derivatives first reported a position in UNH in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.35M in Q3 2017. 1,695 funds tracked by Wall St. Rank hold UNH as of Q1 2018.

  • Integral Derivatives held 4,270 shares of UnitedHealth worth $914K as of Q1 2018.
  • Integral Derivatives bought 345 UnitedHealth shares in Q1 2018, an estimated $78.8K.
  • UnitedHealth made up 0.02% of Integral Derivatives's portfolio in Q1 2018, its #259 holding.
  • Integral Derivatives first reported a position in UnitedHealth in Q4 2013 and has held it in 12 quarters since.
  • Integral Derivatives's UnitedHealth position peaked at $1.35M in Q3 2017.
  • 1,695 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.